邻氨基苯甲酸异丙基胺 | 30391-89-0

• 物质功能分类: 分析化学 - 标准品 - 挥发性有机化合物(VOCs)
• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 中文名称: 邻氨基苯甲酸异丙基胺
• 中文别名: 邻氨基苯甲酸异丙酰胺；2-氨基-n-异丙基苯甲酰胺
• 英文名称: 2-amino-N-isopropylbenzamide
• 英文别名: anthranilic acid-N-isopropylamide；2-amino-N-propan-2-ylbenzamide
• CAS: 30391-89-0
• 化学式: C₁₀H₁₄N₂O
• mdl: MFCD00143620
• 分子量: 178.234
• InChiKey: FWQYJOPJMIEKHZ-UHFFFAOYSA-N

物化性质

• 熔点：
  147 °C
• 沸点：
  355.7±25.0 °C(Predicted)
• 密度：
  1.077±0.06 g/cm3(Predicted)
• 溶解度：
  可溶于氯仿（少许）、甲醇（少许）

计算性质

• 辛醇/水分配系数(LogP)：
  1.4
• 重原子数：
  13
• 可旋转键数：
  2
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.3
• 拓扑面积：
  55.1
• 氢给体数：
  2
• 氢受体数：
  2

安全信息

• 危险等级：
  IRRITANT
• 危险品标志：
  Xn,Xi
• 安全说明：
  S26
• 危险类别码：
  R22,R36/37/38
• WGK Germany：
  3
• 海关编码：
  2924299090
• 储存条件：
  存储条件：2-8℃，避光，惰性气体保护。

SDS

---

SECTION 1: Identification of the substance/mixture and of the company/undertaking
Product identifiers
Product name : 2-Amino-N-(isopropyl)benzamide
REACH No. : A registration number is not available for this substance as the substance
or its uses are exempted from registration, the annual tonnage does not
require a registration or the registration is envisaged for a later
registration deadline.
CAS-No. : 30391-89-0
Relevant identified uses of the substance or mixture and uses advised against
Identified uses : Laboratory chemicals, Manufacture of substances

---

SECTION 2: Hazards identification
Classification of the substance or mixture
Classification according to Regulation (EC) No 1272/2008
Acute toxicity, Oral (Category 4), H302
Skin irritation (Category 2), H315
Eye irritation (Category 2), H319
Specific target organ toxicity - single exposure (Category 3), H335
For the full text of the H-Statements mentioned in this Section, see Section 16.
Classification according to EU Directives 67/548/EEC or 1999/45/EC
Xn Harmful R22, R36/37/38
For the full text of the R-phrases mentioned in this Section, see Section 16.
Label elements
Labelling according Regulation (EC) No 1272/2008
Pictogram
Signal word Warning
Hazard statement(s)
H302 Harmful if swallowed.
H315 Causes skin irritation.
H319 Causes serious eye irritation.
H335 May cause respiratory irritation.
Precautionary statement(s)
P261 Avoid breathing dust/ fume/ gas/ mist/ vapours/ spray.
P305 + P351 + P338 IF IN EYES: Rinse cautiously with water for several minutes. Remove
contact lenses, if present and easy to do. Continue rinsing.
Supplemental Hazard none
Statements
Other hazards - none

---

SECTION 3: Composition/information on ingredients
Substances
Formula : C10H14N2O
Molecular Weight : 178,23 g/mol
CAS-No. : 30391-89-0
EC-No. : 250-175-4
Hazardous ingredients according to Regulation (EC) No 1272/2008
Component Classification Concentration
2-Amino-N-(isopropyl)benzamide
Acute Tox. 4; Skin Irrit. 2; Eye -
Irrit. 2; STOT SE 3; H302,
H315, H319, H335
Hazardous ingredients according to Directive 1999/45/EC
Component Classification Concentration
2-Amino-N-(isopropyl)benzamide
Xn, R22 - R36/37/38 -
For the full text of the H-Statements and R-Phrases mentioned in this Section, see Section 16

---

SECTION 4: First aid measures
Description of first aid measures
General advice
Consult a physician. Show this safety data sheet to the doctor in attendance.
If inhaled
If breathed in, move person into fresh air. If not breathing, give artificial respiration. Consult a physician.
In case of skin contact
Wash off with soap and plenty of water. Consult a physician.
In case of eye contact
Rinse thoroughly with plenty of water for at least 15 minutes and consult a physician.
If swallowed
Never give anything by mouth to an unconscious person. Rinse mouth with water. Consult a physician.
Most important symptoms and effects, both acute and delayed
The most important known symptoms and effects are described in the labelling (see section 2.2) and/or in
section 11
Indication of any immediate medical attention and special treatment needed
no data available

---

SECTION 5: Firefighting measures
Extinguishing media
Suitable extinguishing media
Use water spray, alcohol-resistant foam, dry chemical or carbon dioxide.
Special hazards arising from the substance or mixture
Carbon oxides, nitrogen oxides (NOx)
Advice for firefighters
Wear self contained breathing apparatus for fire fighting if necessary.
Further information
no data available

---

SECTION 6: Accidental release measures
Personal precautions, protective equipment and emergency procedures
Use personal protective equipment. Avoid breathing vapours, mist or gas. Ensure adequate ventilation.
Evacuate personnel to safe areas.
For personal protection see section 8.
Environmental precautions
Do not let product enter drains.
Methods and materials for containment and cleaning up
Soak up with inert absorbent material and dispose of as hazardous waste. Keep in suitable, closed
containers for disposal.
Reference to other sections
For disposal see section 13.

---

SECTION 7: Handling and storage
Precautions for safe handling
Avoid contact with skin and eyes. Avoid inhalation of vapour or mist.
Normal measures for preventive fire protection.
For precautions see section 2.2.
Conditions for safe storage, including any incompatibilities
Store in cool place. Keep container tightly closed in a dry and well-ventilated place. Containers which are
opened must be carefully resealed and kept upright to prevent leakage.
Specific end use(s)
A part from the uses mentioned in section 1.2 no other specific uses are stipulated

---

SECTION 8: Exposure controls/personal protection
Control parameters
Components with workplace control parameters
Exposure controls
Appropriate engineering controls
Handle in accordance with good industrial hygiene and safety practice. Wash hands before breaks and
at the end of workday.
Personal protective equipment
Eye/face protection
Face shield and safety glasses Use equipment for eye protection tested and approved under
appropriate government standards such as NIOSH (US) or EN 166(EU).
Skin protection
Handle with gloves. Gloves must be inspected prior to use. Use proper glove removal technique
(without touching glove's outer surface) to avoid skin contact with this product. Dispose of
contaminated gloves after use in accordance with applicable laws and good laboratory practices.
Wash and dry hands.
The selected protective gloves have to satisfy the specifications of EU Directive 89/686/EEC and
the standard EN 374 derived from it.
Body Protection
Complete suit protecting against chemicals, The type of protective equipment must be selected
according to the concentration and amount of the dangerous substance at the specific workplace.
Respiratory protection
Where risk assessment shows air-purifying respirators are appropriate use a full-face respirator
with multi-purpose combination (US) or type ABEK (EN 14387) respirator cartridges as a backup
to engineering controls. If the respirator is the sole means of protection, use a full-face supplied air
respirator. Use respirators and components tested and approved under appropriate government
standards such as NIOSH (US) or CEN (EU).
Control of environmental exposure
Do not let product enter drains.

---

SECTION 9: Physical and chemical properties
Information on basic physical and chemical properties
a) Appearance Form: liquid
b) Odour no data available
c) Odour Threshold no data available
d) pH no data available
e) Melting point/freezing Melting point/range: 10 - 12 °C
point
f) Initial boiling point and 214 °C at 985 hPa
boiling range
g) Flash point no data available
h) Evapouration rate no data available
i) Flammability (solid, gas) no data available
j) Upper/lower no data available
flammability or
explosive limits
k) Vapour pressure no data available
l) Vapour density no data available
m) Relative density 0,984 g/cm3 at 25 °C
n) Water solubility no data available
o) Partition coefficient: n- log Pow: 1,44
octanol/water
p) Auto-ignition no data available
temperature
q) Decomposition no data available
temperature
r) Viscosity no data available
s) Explosive properties no data available
t) Oxidizing properties no data available
Other safety information
no data available

---

SECTION 10: Stability and reactivity
Reactivity
no data available
Chemical stability
Stable under recommended storage conditions.
Possibility of hazardous reactions
no data available
Conditions to avoid
no data available
Incompatible materials
Strong oxidizing agents
Hazardous decomposition products
Other decomposition products - no data available
In the event of fire: see section 5

---

SECTION 11: Toxicological information
Information on toxicological effects
Acute toxicity
no data available
Inhalation: no data available
Skin corrosion/irritation
no data available
Serious eye damage/eye irritation
no data available
Respiratory or skin sensitisation
no data available
Germ cell mutagenicity
no data available
Carcinogenicity
IARC: No component of this product present at levels greater than or equal to 0.1% is identified as
probable, possible or confirmed human carcinogen by IARC.
Reproductive toxicity
no data available
Specific target organ toxicity - single exposure
Inhalation - May cause respiratory irritation.
Specific target organ toxicity - repeated exposure
no data available
Aspiration hazard
no data available
Additional Information
RTECS: Not available
To the best of our knowledge, the chemical, physical, and toxicological properties have not been
thoroughly investigated.

---

SECTION 12: Ecological information
Toxicity
no data available
Persistence and degradability
no data available
Bioaccumulative potential
no data available
Mobility in soil
no data available
Results of PBT and vPvB assessment
PBT/vPvB assessment not available as chemical safety assessment not required/not conducted
Other adverse effects
no data available

---

SECTION 13: Disposal considerations
Waste treatment methods
Product
Offer surplus and non-recyclable solutions to a licensed disposal company. Contact a licensed
professional waste disposal service to dispose of this material.
Contaminated packaging
Dispose of as unused product.

---

SECTION 14: Transport information
UN number
ADR/RID: - IMDG: - IATA: -
UN proper shipping name
ADR/RID: Not dangerous goods
IMDG: Not dangerous goods
IATA: Not dangerous goods
Transport hazard class(es)
ADR/RID: - IMDG: - IATA: -
Packaging group
ADR/RID: - IMDG: - IATA: -
Environmental hazards
ADR/RID: no IMDG Marine pollutant: no IATA: no
Special precautions for user
no data available

---

---

SECTION 15 - REGULATORY INFORMATION
N/A

---

SECTION 16 - ADDITIONAL INFORMATION
N/A

制备方法与用途

概述

邻氨基苯甲酸异丙酰胺可用作医药合成中间体，如制备灭草松。灭草松是一种重要的苗后除草剂，其化学名为3-异丙基-(1H)-苯并-2,1,3-噻二嗪-4-酮-2,2-二氧化物，最初由德国BASF公司研发成功并在世界范围内大量使用。它具有选择性的触杀作用，用于杂草苗期茎叶处理，具备较强的触杀性、良好的选择性和高效见草杀草的特点，主要用于水稻、大豆、花生和小麦等作物，专门防除阔叶杂草和莎草科杂草，对禾本科杂草无效。

用途

邻氨基苯甲酸异丙酰胺可用作医药合成中间体，如制备灭草松。

制备

邻氨基苯甲酸异丙酰胺的制备方法如下：将靛红酸酐溶于二氯乙烷中，边升温边滴加异丙胺，待温度升至60℃后，保温0.8小时。随后用饱和碳酸钠洗涤以脱除二氯乙烷，得到浅黄色邻氨基-N-异丙基苯甲酰胺溶液。制备过程中，靛红酸酐、二氯乙烷和异丙胺的质量比为3.5：2.6：1.8。

反应信息

• 作为反应物：
  描述：

  邻氨基苯甲酸异丙基胺 在 红铝 作用下， 生成 2-((isopropylamino)methyl)aniline
  参考文献：
  名称：

  3-烷基-3,4-二氢-2（1 H）-喹唑啉酮类化合物的合成及其抗惊厥活性

  摘要：

  以前我们报道了3-二甲基氨基-3,4-二氢-2（1 H）-喹唑啉酮的强效抗惊厥活性。在此报告中，三步合成了一系列的3-烷基-3,4-二氢-2（1 H）-喹唑啉酮，是由等角酸酐或邻氨基苯甲酸合成的。结构/活性研究揭示了3-异丙基和3-环己基类似物的最佳活性。这些化合物对最大电击诱发的癫痫发作有效。

  DOI：

  10.1002/jhet.5570290117
• 作为产物：
  描述：

  邻硝基苯甲酸 在 甲醇 、 氯化亚砜 、 铁粉 、 氯化铵 作用下， 以 水 为溶剂， 反应 7.0h， 生成 邻氨基苯甲酸异丙基胺
  参考文献：
  名称：

  Design and synthesis of diphenylpyrimidine derivatives (DPPYs) as potential dual EGFR T790M and FAK inhibitors against a diverse range of cancer cell lines

  摘要：

  A new class of pyrimidine derivatives were designed and synthesized as potential dual FAK and EGFR(T79)(0M) inhibitors using a fragment-based drug design strategy. This effort led to the identification of the two most active inhibitors, namely 9a and 9f, against both FAK (IC50, = 1.03 and 3.05 nM, respectively) and EGFR(T79)(0M) (IC50 = 3.89 and 7.13 nM, respectively) kinase activity. Moreover, most of these compounds also exhibited strong antiproliferative activity against the three evaluated FAK-overexpressing pancreatic cancer (PC) cells (AsPC-1, BxPC-3, Panc-1) and two drug-resistant cancer cell lines (breast cancer MCF-7/adr cells and lung cancer H1975 cells) at concentrations lower than 6.936 mu M. In addition, 9a was also effective in the in vivo assessment conducted in a FAK-driven human AsPC-1 cell xenograft mouse model. Overall, this study offers a new insight into the treatment of hard to treat cancers.

  DOI：

  10.1016/j.bioorg.2019.103408

文献信息

• Diversified facile synthesis of benzimidazoles, quinazolin-4(3H)-ones and 1,4-benzodiazepine-2,5-diones via palladium-catalyzed transfer hydrogenation/condensation cascade of nitro arenes under microwave irradiation
  作者：Kaicheng Zhu、Jian-Hong Hao、Cheng-Pan Zhang、Jiajun Zhang、Yiqing Feng、Hua-Li Qin

  DOI：10.1039/c4ra15765f

  日期：——

  An efficient methodology for diversified preparation of benzimidazole, quinazolin-4(3H)-ones and 1,4-benzodiazepine-2,5-diones is established using a Pd-CTH/condensation cascade of nitro arenes in a TEA–formic acid mixture under microwave irradiation.

  一种高效的方法学已建立，用于在微波辐射下利用Pd-CTH/缩合级联反应在TEA-甲酸混合物中多样化制备苯并咪唑、喹唑啉-4(3H)-酮和1,4-苯二氮杂环己酮。
• Studies on 4(1H)-Quinazolinones. 5. Synthesis and Antiinflammatory Activity of 4(1H)-Quinazolinone Derivatives
  作者：Ken-ichi Ozaki、Yoshihisa Yamada、Toyonari Oine、Tōru Ishizuka、Yoshio Iwasawa

  DOI：10.1021/jm50001a006

  日期：1985.5

  new 4(1H)-quinazolinones were synthesized and evaluated in the carrageenin-induced paw edema test. Most of the compounds were obtained by the cyclization of the appropriately substituted anthranilamides with acid chlorides, followed by further chemical transformation. Structure-activity data suggest that 2-isopropyl-1-phenyl-, 2-cyclopropyl-1-phenyl-, and 1-isopropyl-2-phenyl-4(1H)-quinazolinones afford

  合成了许多新的4（1H）-喹唑啉酮，并在角叉菜胶诱导的爪水肿试验中进行了评估。大多数化合物是通过将适当取代的邻氨基苯甲酰胺与酰氯环合，然后进一步化学转化而获得的。结构活性数据表明2-异丙基-1-苯基-，2-环丙基-1-苯基-和1-异丙基-2-苯基-4（1H）-喹唑啉酮具有最佳效价，卤素原子的存在为首选活动。肾上腺切除术不影响抗炎测试结果。1-异丙基-（2-氟苯基）-4-（1H）-喹唑啉酮（50）显示出兼顾功效和副作用的最佳结果。
• ANTHRANILAMIDE INHIBITORS OF AURORA KINASE
  申请人：Johnson Neil W.

  公开号：US20080182852A1

  公开（公告）日：2008-07-31

  The present invention relates to a compound represented by the following formula: or a pharmaceutically acceptable salt thereof; where R 1 , R 2 , R 3 , R 4 , r and s are as previously defined. Compounds of the present invention are useful in the treatment of diseases associated with Aurora kinase activity such as cancer.

  本发明涉及以下公式所代表的化合物： 或其药学上可接受的盐； 其中R1、R2、R3、R4、r和s如前所定义。本发明的化合物在治疗与Aurora激酶活性相关的疾病，如癌症方面是有用的。
• Copper-Catalyzed Oxidative Cyclization of 2-Aminobenzamide Derivatives: Efficient Syntheses of Quinazolinones and Indazolones
  作者：Wei-Yu Lin、Karthick Govindan、Tamilselvan Duraisamy、Alageswaran Jayaram、Gopal Chandru Senadi

  DOI：10.1055/a-1667-3977

  日期：2022.2

  transformations are based on the fact that DMF can serve as a reaction solvent and one carbon synthon for the construction of heterocyclic rings. Moreover, this protocol features base-free and Brønsted acid free environmentally benign conditions with broad synthetic scope. A good scalability is demonstrated.

  报道了一种简单的铜催化组装，以单一协议方式配制喹唑啉酮和吲唑酮衍生物。这些转化是基于 DMF 可以作为反应溶剂和一个碳合成子来构建杂环的事实。此外，该协议具有无碱和无布朗斯台德酸的环境良性条件，具有广泛的合成范围。展示了良好的可扩展性。
• I₂-Catalyzed Aerobic Oxidative C(sp³)–H Amination/C–N Cleavage of Tertiary Amine: Synthesis of Quinazolines and Quinazolinones
  作者：Yizhe Yan、Ying Xu、Bin Niu、Huifang Xie、Yanqi Liu

  DOI：10.1021/acs.joc.5b00474

  日期：2015.6.5

  An iodine-catalyzed oxidative C(sp3)–H amination/C–N cleavage of tertiary amines couducted under an oxygen atmosphere has been developed and affords a route to quinazolines and quinazolinones in good to excellent yields via a domino ring annulation. The method is metal-free, peroxide-free, and operationally simple to implement with a wide scope of substrates and represents a new avenue for multiple

  在氧气气氛下，碘催化的氧化叔胺的C（sp 3）-H胺化/ C-N氧化催化氧化反应已被开发出来，并通过多米诺环化法提供了一条以优异的产率获得喹唑啉和喹唑啉酮的途径。该方法无金属，无过氧化物，并且操作简便，可在多种基材上实施，为形成多个C–N键形成了新途径。